ArticleBiosensors & bioelectronics2023
A high-throughput fully automatic biosensing platform for efficient COVID-19 detection.
Article in Biosensors & bioelectronics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 25 citations in OpenAlex.
- Optical and Electrochemical Biosensors Using Electrochemically Etched Porous Silicon.Biosensors · 2026Review
- Tailoring porosity and surface functionalization in nanoporous anodic alumina rugate filters for enhanced interferometric biosensing.Nanoscale advances · 2026Article
- Next-generation COVID-19 detection using a metasurface biosensor with machine learning-enhanced refractive index sensing.Scientific reports · 2025Article
- Review
- Optical Biosensor Based on Porous Silicon and Tamm Plasmon Polariton for Detection of CagA Antigen ofSensors (Basel, Switzerland) · 2024Article
- Automation and Computerization of (Bio)sensing Systems.ACS sensors · 2024Review
- Tamm Plasmon Polariton Biosensors Based on Porous Silicon: Design, Validation and Analysis.Biosensors · 2023Article
- Biosensors for waterborne virus detection: Challenges and strategies.Journal of pharmaceutical analysis · 2023Review
- Machine Learning Techniques for Effective Pathogen Detection Based on Resonant Biosensors.Biosensors · 2023Article
- A Closed-Loop Approach to Fight Coronavirus: Early Detection and Subsequent Treatment.Biosensors · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We propose a label-free biosensor based on a porous silicon resonant microcavity and localized surface plasmon resonance. The biosensor detects SARS-CoV-2 antigen based on engineered trimeric angiotensin converting enzyme-2 binding protein, which is conserved across different variants. Robotic arms run the detection process including sample loading, incubation, sensor surface rinsing, and optical measurements using a portable spectrometer. Both the biosensor and the optical measurement system are readily scalable to accommodate testing a wide range of sample numbers. The limit of detection is 100 TCID
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.